Category: CovidienSyndicate content

Covidien's ev3 seeks new trial in $175M loss to Appriva

March 13, 2014 by Brad Perriello

Covidien's ev3 subsidiary asks the Delaware Supreme Court for a new trial over the $175 million in milestones Appriva Medical alleges are owed from a 2002 acquisition.

Covidien's ev3 seeks new trial in $175M loss to Appriva

Covidien (NYSE:COV) subsidiary ev3 wants the Delaware Supreme Court to grant a new trial in a lawsuit over $175 million ev3 allegedly owes its own Appriva Medical acquisition.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA OKs Integra LifeSciences foot bone wedges

March 13, 2014 by Chris Walker

The FDA clears the titanium bone wedges made by Integra LifeSciences for use in repairing foot bone fractures.

FDA OKs Integra LifeSciences foot bone wedges

Integra LifeSciences (NSDQ:IART) said it obtained 510(k) clearance from the FDA for its Integra titanium bone wedges.

The wedges are designed for corrective procedures, such as osteotomies, in treating fractures in foot bones, according to a press release.

Medtech trends: The most talked about device makers in February 2014

March 4, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Covidien touts U.S, European wins for new ventilator

March 4, 2014 by Arezu Sarvestani

Medtech titan Covidien lands regulatory wins in the U.S. and the European Union for its next-generation Puritan Bennett 980 ventilator.

Covidien touts U.S, European wins for Puritan Bennett 980 ventilator

Massachusetts-based Covidien (NYSE:COV) landed European and U.S. regulatory wins for its new Puritan Bennett 980 ventilator.

Covidien closes $860M Given Imaging buy

February 27, 2014 by Brad Perriello

Covidien closes the $860 million acquisition of Given Imaging and its PillCam capsule endoscope.

Covidien closes $860M Given Imaging buy

Covidien (NYSE:COV) said it closed the buyout of Given Imaging and its PillCam imaging device for about $860 million, net of cash and investments.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Welch Allyn debuts monitor with tech from Masimo, Covidien, EarlySense

February 11, 2014 by Chris Walker

Welch Allyn debuts a new Connex clinical surveillance system featuring monitoring technology from Masimo, Covidien and EarlySense.

Welch Allyn launches integrated surveillance system

Covidien's Endo Gia stapler wins FDA nod

February 10, 2014 by Chris Walker

Covidien wins 510(k) clearance from the FDA for its Endo Gia surgical stapler.

Covidien lands 510(k) for surgical staples

Covidien (NYSE:COV) won 510(k) clearance from the FDA for its Endo Gia surgical stapler.

The Endo Gia, which uses an advanced polymer felt material to provide additional support to fragile tissue, landed Japanese approval in late January.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp